Standout Papers

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-control... 2023 2026 202481
  1. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial (2023)
    Martina Schneider, Robert P. McMahon et al. The Lancet

Immediate Impact

2 by Nobel laureates 56 standout
Sub-graph 1 of 24

Citing Papers

Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded
2024 Standout
Precise modulation and use of reactive oxygen species for immunotherapy
2024 Standout
2 intermediate papers

Works of Vera Buerger being referenced

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
2010
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine
2010

Author Peers

Author Last Decade Papers Cites
Vera Buerger 168 189 226 188 12 457
Gabriela Hrebikova 77 207 175 293 14 502
Sandra Sparacio 195 181 132 141 8 452
Adam Zuiani 201 199 101 68 9 473
Kenn Forberg 183 131 162 92 19 419
Prisca Susan A. Leaño 150 194 147 104 17 408
Reinhard Glueck 69 166 309 84 19 471
Robert J. Feighny 212 246 145 81 16 511
M Ranki 88 153 143 45 21 486
Mariarosaria Naddeo 57 52 142 107 11 398
Bruce J. Dille 102 121 293 209 12 453

All Works

Loading papers...

Rankless by CCL
2026